About Uncharacterized protein C9orf43
Uncharacterized protein C9orf43 (C9orf43) is a protein
from Homo sapiens identified by UniProt accession
Q8TAL5, 461 residues long.
MolForge cross-references it against 0 known binders and
62 disease associations.
Target properties
| Protein name | Uncharacterized protein C9orf43 |
| UniProt accession | Q8TAL5 |
| Gene | C9orf43 |
| Organism | Homo sapiens |
| Length | 461 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (62)
Diseases linked to this target (Open Targets).
- systolic blood pressure · score 0.38
- body height · score 0.23
- mean platelet volume · score 0.21
- platelet count · score 0.20
- hematocrit · score 0.17
- red blood cell density measurement · score 0.16
- sitting height measurement · score 0.13
- hemoglobin measurement · score 0.13
- erythrocyte count · score 0.12
- Abnormality of refraction · score 0.09
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8TAL5-F1 | alphafold | PREDICTED | 46.63 | — |
Amino-acid sequence (461 residues)
MDLPDESQWD ETTCGLAVCQ HPQCWATIRR IERGHPRILG SSCKTPLDAE DKLPVLTVVD ILDSGFAAHH LPECTFTKAH SLLSQSSKFY SKFHGRPPKG LPDKSLINCT NRLPKFPVLN LNETQLPCPE DVRNMVVLWI PEETEIHVSQ HGKKKRKNSA VKSKSFLGLS GNQSAGTRVG TPGMIVPPPT PVQLSEQFSS DFLPLWAQSE ALPQDLLKEL LPGGKQTMLC PEMKIKLAMM KKNLPLEKNR PDSVISSKMF LSIHRLTLER PALRYPERLK KLHNLKTEGY RKQQQRQQQQ QQQQKKVKTP IKKQEAKKKA KSDPGIQSTS HKHPVTTVHD RLYGYRTLPG QNSDMKQQQQ MEKGTTSKQD STERPKMNYY DHADFHHSVK SPELYETEPT NKDISAPVDA VPEAQAARQK KISFNFSEIM ASTGWNSELK LLRILQDTDD EDEEDQSSGA E
Explore Uncharacterized protein C9orf43 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets